| FFBFX | FSLBX | FFBFX / FSLBX | |
| Total Expense Ratio | 1.89 | 0.66 | 286% |
| Annual Report Gross Expense Ratio | 1.89 | 0.66 | 286% |
| Fund Existence | 17 years | 41 years | - |
| Gain YTD | 6.721 | -4.955 | -136% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 47.7M | 992M | 5% |
| Annual Yield % from dividends | 0.00 | 0.65 | - |
| Returns for 1 year | 2.66 | -7.75 | -34% |
| Returns for 3 years | 68.68 | 57.16 | 120% |
| Returns for 5 years | -30.96 | 51.55 | -60% |
| Returns for 10 years | 12.88 | 216.54 | 6% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HWSIX | 95.84 | N/A | N/A |
| Hotchkis & Wiley Small Cap Value I | |||
| MVGAX | 18.54 | N/A | N/A |
| MFS Low Volatility Global Equity A | |||
| LYFCX | 18.40 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare C | |||
| FMPTX | 37.06 | N/A | N/A |
| Fidelity Advisor Mid Cap Value M | |||
| JHURX | 52.67 | N/A | N/A |
| JPMorgan Emerging Markets Equity R3 | |||